Mo. Code Regs. Ann. tit. 20, § 200-1.170
PURPOSE: This rule sets forth methods of disclosure, reserving for risk-based capital and determining the asset valuation reserve for derivative instruments used for replication transactions.
(1) An insurer may use derivatives for replication transactions as permitted pursuant to section 375.345, RSMo. An insurer engaging in replication transactions shall:
(A) Comply with the following requirements:
terly statement reporting of such replication transactions;
the insurer’s Risk Based Capital (RBC) Report (as required by sections 375.1250– 375.1275, RSMo); and
reporting of the asset valuation reserve for such transaction;
376.300–376.305 and 379.080–379.082, RSMo; provided, that no replicated investment position shall be held pursuant to the additional investment authority contained in sections 376.307 and 379.080.1(2)(m) and (o), RSMo.
AUTHORITY: sections 374.045, RSMo 2000 and 375.345, RSMo Supp. 2005.* Original rule filed Dec. 15, 2005, effective June 30, 2006. Non-substantive change filed Sept. 11, 2019, published Oct. 31, 2019.
*Original authority: 374.045, RSMo 1967, amended 1993, 1995 and 375.345, RSMo 1985, amended 2002.